Feldan is attending the Annual meeting of ASGCT in Washington DC, USA.
Come meet our Research Director, David Guay to learn more about our Shuttle technology during the 19th Annual Meeting of the American Society of Gene and Cell Therapy ASGCT In Washington DC, USA on May 4th-7th 2016.
Poster Presentation: Friday May 6th, 2016 – 6:00pm – 8:00pm
The American Society of Gene & Cell Therapy (ASGCT) is a non-profit medical and professional organization that represents researchers and scientists devoted to the discovery of new genetic and cellular therapies. ASGCT was established in 1996 by Dr. George Stamatoyannopoulos, professor of medicine at the University of Washington’s School of Medicine and a group of the country’s leading researchers in gene therapy. With nearly 1,800 members in the United States and worldwide, ASGCT is the largest association of individuals involved in genetic and cellular therapeutics.
ASGCT’s mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.
ASGCT’s strategic vision is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.
Save the date and plan to head to Washington, DC on May 4-7, 2016, for the premiere gene and cell therapy conference in the world. Taking place at the Marriott Wardman Park Hotel, the ASGCT 19th Annual Meeting will feature ground breaking clinical trial results, cutting edge technology advancements, social networking events, and much more.